Nov 11 (Reuters) - Eli Lilly ( LLY ) is dropping CVS

Health's ( CVS ) drug benefit plan for its employees after CVS

stopped covering its weight-loss drug in favor of a rival

medication from Novo Nordisk, Bloomberg News reported

on Tuesday, citing people familiar with the matter.

Beginning on January 1, Lilly employees covered by the

company's medical plan will automatically be enrolled with

pharmacy benefit coverage through a privately held pharmacy

benefit manager called Rightway, Bloomberg said, citing a

document viewed by them.

Reuters could not immediately verify the Bloomberg report.